|
||
Journal of Experimental Medicine, Vol 174, 1313-1322, Copyright © 1991 by Rockefeller University Press
ARTICLES |
AA Postigo, AL Corbi, F Sanchez-Madrid and MO de Landazuri
Servicio de Immunologia, Hospital de la Princesa, Universidad Autonoma de Madrid, Spain.
CD11c/CD18 (p150,95) is a beta 2 integrin expressed by myeloid, natural killer and certain lymphoid cells such as some cytotoxic T cell clones and B cell malignancies. We have studied the expression and function of CD11c on resting and activated B lymphocytes. Flow cytometry, immunoprecipitation, and mRNA analyses showed that cell activation with phorbol esters or with a variety of stimuli such as Staphylococcus aureus or anti-mu antibodies in combination with cytokines induced de novo CD11c/CD18 cell surface expression on most B cells while CD11b expression was not affected. Functional analysis of CD11c/CD18 on B cells revealed that it plays a dual role. First, CD11c/CD18 is implicated in B cell proliferation, as demonstrated by the ability of several anti-CD11c monoclonal antibodies to trigger comitogenic signals; and second, the newly expressed CD11c/CD18 mediates B cell binding to fibrinogen. Our data conclusively demonstrate the role of CD11c/CD18 on both B cell activation and adhesion processes.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|